NuVasive Boosts Artificial Disc Development, Stock; OTC Index Rises 15%
This article was originally published in The Gray Sheet
Executive Summary
NuVasive will use profits gained from a series of 510(k)-cleared spinal devices to fuel artificial disc and nucleus replacement development in 2006